Background: During transradial (TR) access, it remains unclear whether differences in baseline
Methods and Results: The Radial Artery Patency and Bleeding, Efficacy, Adverse evenT (RAP and BEAT) trial randomized 1,836 patients undergoing TR coronary angiography and/or interventions to receive the GSS6Fr or the standard 5 Fr Glidesheath (GS5Fr, Terumo, Japan). Out of this study population, 1,087 were Japanese patients and 751 non-Japanese patients. The overall incidence of RAO was significantly higher in Japanese patients (3.6% vs. 1.2%, P 5 0.002). Use of GSS6Fr was associated with higher rates of RAO than GS5Fr in Japanese patients (5% vs. 2.2%, P 5 0.02) and with similar RAO rates in non-Japanese patients (1.3 vs. 1.1%, P 5 1). The mean hemostasis time was significantly longer in Japanese patients (378 6 253 vs. 159 6 136 min, P < 0.001) and more Japanese patients had a hemostasis time of more than 6 hr (16.2% vs. 4.9%, P < 0.0001). Longer hemostasis time was an independent predictor of RAO (OR per additional hour 1.070, 95% CI 1.008-1.136, P 5 0.03).
Conclusions: Use of GSS6Fr was associated with a higher rate of RAO than a standard 5 Fr sheath in Japanese patients but not in non-Japanese patients. Whether improvement in post-procedural care and reduced hemostasis time could impact the incidence of RAO in Japanese patients should be further assessed.
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| I N TR ODU C TI ON
Radial artery occlusion (RAO) remains a significant drawback of transradial (TR) access, restricting the use of the radial artery for future procedures [1, 2] . An inherent limitation of TR access is related to the small size of the radial artery, suggesting that the use of a sheath larger than the inner lumen of the radial artery is a risk factor for radial artery injury and subsequent RAO [3] [4] [5] [6] . Miniaturization of TR equipment has been advocated to reduce the occurrence and importance of the sheath-to-artery (S/A) mismatch. The 6 French (Fr) Glidesheath Slender (GSS6Fr, Terumo, Japan) is the first commercially available thin-walled radial sheath with an outer diameter (OD) smaller than the OD of current standard 6 Fr sheaths [7] . The Radial Artery Patency and Bleeding, Efficacy, Adverse evenT (RAP and BEAT) trial was a large randomized, multicenter trial, assessing non-inferiority of the GSS6Fr against the standard 5 Fr Glidesheath (GS5Fr, Terumo, Japan), and superiority of a patent hemostasis protocol against the institutional hemostasis protocol, in 1,836 patients undergoing TR coronary angiography and/or intervention [8] . The RAP and BEAT trial showed that use of the GSS6Fr was associated with a low event rate for the primary outcome (RAO) although non-inferiority against the GS5Fr was not met, due to a lower than expected rate of RAO in the GS5Fr group. Patients randomized to patent hemostasis had a similar rate of RAO to those assigned to institutional hemostasis. The study population was intercontinental and included 1,087 Japanese patients and 751 nonJapanese patients. As such, it provides an ideal opportunity to study whether patient-level differences affect RAO. For example, Japanese patients may have smaller radial arteries, resulting in a higher incidence of radial artery injury and occlusion when using larger sheaths [9] [10] [11] .
Furthermore, little is known about the impact of hemostasis care on the rate of RAO in different populations undergoing TR access. The purpose of this study is therefore to compare the rate of RAO and secondary clinical outcomes in Japanese and non-Japanese patients after TR coronary angiography and/or interventions with the GSS6Fr or the standard GS5Fr.
| M ET HOD S

| Study design and participants
Radial Artery Patency and Bleeding, Efficacy, Adverse evenT was an international multicenter, prospective, single-blind, randomized clinical trial using a 2X2 factorial design, assessing non-inferiority of the GSS6Fr against the GS5Fr, and superiority of patent hemostasis against institutional hemostasis, in patients undergoing TR coronary angiography and/or interventions (ClinicalTrials.gov NCT02269449). The trial was conducted at 12 centers in Japan, Europe and the United States (US). Patients were eligible if they were to undergo TR coronary angiography and/or intervention. General exclusion criteria were as follows:
(1) inability to puncture the radial artery, (2) presence of another medical illness that may cause non-compliance with the protocol or confound data interpretation, (3) hemodialysis patient, and (4) patients with acute coronary syndrome. The trial was approved by the institutional review board of each participating center, and all patients gave written informed consent. sheath. An adjunctive bolus of Heparin was given during PCI if needed to achieve an activated clotting time range of 250-300 sec. After completion of the TR procedure, the arterial sheath was removed and hemostasis was performed according to patient randomization (patent hemostasis protocol versus institutional hemostasis protocol). Details regarding hemostasis protocols are described in the main article.
| Study protocol and randomization
| Study outcomes
The primary endpoint was the rate of RAO at discharge, defined as the absence of a radial pulse assessed clinically together with the absence of flow on Doppler ultrasound examination of the radial artery. The physician assessing radial patency was blinded to the assigned sheath.
Secondary end-points were procedural success, vascular access-site complication, local bleeding, radial spasm, total procedural time, total amount of contrast dye, total radiation dose, sheath failure, and pain score. Procedural success was defined as completion of the planned procedure through the initially selected radial access route. A vascular access-site complication was defined as any documented vascular damage that included but was not limited to vessel perforation, arterial dissection, pseudoaneurysm, and local hematoma. Radial spasm was defined as an inability to manipulate the guidewire or catheter in a smooth and pain-free manner and also as an inability to remove the sheath in a similar way at the end of the procedure. The diagnosis of puncture site bleeding was made by visual assessment before discharge and classified according to the EASY criteria [7] . Sheath failure was defined as any device malformation leading to vascular complication and/or procedural failure. Pain score denoted the patient's assessment of pain during radial artery sheath removal (1 5 none, 2 5 slight, 3 5 much, and 4 5 extreme). 
| Statistical analysis
Categorical data are presented as numbers and percentages and compared using the Chi-square test. Continuous data are presented as mean with standard deviation (SD) and compared using the MannWhitney U test. Potential risk factors for post-procedural RAO were investigated first by univariate logistic regression. A multivariate logistic regression model was used to identify predictors of RAO and was created using a stepwise selection procedure, assessing all variables with a univariate P-value <0.10 for difference between the RAO(1) and RAO (2) subgroups. In the stepwise selection procedure, variables were included, step by step, if they achieved a multivariate P-value of 0.30 and were retained if they maintained a multivariate P-value of <0.10.
As compared to the original analysis performed for the main trial, we added patient population (Japanese vs. non-Japanese patients), age effect per 10 years, and hemostasis time as a continuous variable (per hour) as covariates for the prediction of RAO. A two-sided P < 0.05 was considered significant for all tests. All analyses were performed using SAS version 9.4 (SAS Statistical Software, The SAS Institute, Cary, NC).
| RE S U L TS
The RAP and BEAT trial randomized 1,838 patients at 12 centers in Japan, Europe, and USA. Out of this study population, 1,087 patients were enrolled in five Japanese centers, 601 patients in five European centers, and 150 patients in two US centers (non-Japanese study population 5 751). Baseline clinical and procedural characteristics of the two study populations are shown in Table 1 . Japanese patients were older (71.2 6 10 vs. 64.5 6 11 years, P < 0.001), shorter (161.5 6 9 vs.
171.3 6 12 cm, P < 0.001) and had lower body weight (62.7 6 12 vs.
86.4 6 18.3 kg, P < 0.001). Previous access on the same radial artery was noted in 34.7% in Japanese patients and 16.8% of non-Japanese patients (P < 0.001). Elective or ad-hoc PCI was significantly less frequent in Japanese patients (7.5% vs. 22.4%, P < 0.001) and the mean used catheter size was smaller in Japanese patients (4.3 6 0.6 Fr vs.
5.3 6 0.5 Fr, P < 001). Fewer Japanese patients were on Aspirin treatment at the time of randomization (55.8% vs. 77.6%, P < 0.001). Importantly, the mean hemostasis time was significantly longer in Japanese patients (378 6 253 vs. 159 6 136 min, P < 0.001) and more Japanese patients had a hemostasis time of more than 6 hr (16.2% vs. 4.9%, OR 3.73, 95% CI 2.58-5.39, P < 0.0001). In non-Japanese patients, there was no difference in the mean hemostasis time between GSS6Fr and GS5Fr (161.2 6 143.1 vs. 157.3 6 128.1 min, P 5 0.693) whereas Japanese patients experienced longer hemostasis time with GSS6Fr
(398.9 6 273 vs. 356.6 6 230 min, P 5 0.0058). The study end-points are shown in Table 2 . The overall incidence of RAO at discharge was significantly increased in Japanese patients (3.6% vs. 1.2%, P 5 0.002).
Use of the GSS6Fr was associated with higher rates of RAO than the GS5Fr in Japanese patients (5% vs. 2.2%, P 5 0.02) and with similar RAO rates in non-Japanese patients (1.3 vs. 1.1%, P 5 0.99) (Figure 1 ).
Japanese patients were also associated with significantly more accesssite bleeding (OR 1.72, 95% CI 1.33-2.22, P < 0.0001), pain during the procedure (OR 3.82, 95% CI 3.04-4.8, P < 0.0001) and procedural failure (OR 5.6, 95% CI 1.28-24.4, P 5 0.013). Univariate predictors of RAO are shown in Table 3 . On multivariate analysis, hemostasis time was found to be an independent predictor of RAO (OR per additional During TR access, use of a sheath larger than the inner lumen of the radial artery promotes vascular injury and is a strong predictor of RAO [5, 6, 10] . Radial artery size has been shown to vary between different study populations with Asian patients being associated with smaller radial artery diameters than Caucasian patients [9] [10] [11] [12] [13] . Using ultrasound imaging, Horie et al. have shown that the mean diameter of the radial artery was 2.20 6 0.45 mm in a Japanese population of 300 patients undergoing TR PCI with GSS6Fr. As such, use of GSS6Fr resulted in the occurrence of a S/A ratio >1 in 74% of patients and a mean S/A ratio of 1.17 6 0.27. In their study, use of the GSS6Fr was associated with a higher combined rate of RAO and spasm than a 6.5
Fr Sheathless guiding catheter (0.7% vs. 3.7%, P 5 0.021) [11] . Similarly, we can assume that the small difference in OD between the GSS6Fr (2.46 mm) and the GS5Fr (2.29 mm) was likely associated with a higher rate of radial artery overstretch and subsequent injury in our Japanese study population. This is further supported by the significant increase in pain score noted in these patients. Of note, Aspirin pretreatment was independently associated with a lower rate of RAO. Since acute RAO is thought to be due to a thrombotic process, the positive impact of Aspirin pretreatment on RAO should be assessed in future studies.
Our finding that Japanese patients had significantly longer hemostasis high rate of patent hemostasis and a low rate of early RAO, as compared to a standard deflation technique (2% vs. 14.5%, P 5 0.005) [16] .
In another recent trial that has included pooled data from 3,616 patients randomized to three consecutive protocols, the rate of RAO was markedly reduced when hemostatic compression was soft (10 cc of air in the TR Band) and short (1.5 hr), resulting in a 2.3% rate of 
